Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influcid tablets for upper respiratory tract infections with flu-like symptoms
2010-021422-35Phase 3Completed
- Sponsor
- Deutsche Homöopathie-Union
- Start
- Aug 2010
- Countries
- 1
01
Overview
Phase 3 trial of Influcid in upper respiratory infection (URI), sponsored by Deutsche Homöopathie-Union. Primary endpoints: Symptom alleviation at day 4 and Time to symptom alleviation. Started Aug 2010; status: completed.
02
Drugs
Influcid
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2010-021422-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021422-35.